Search research articles
Contact Us
Filters
Showing results (101-110 of 166) with videos related to
Page
of 17
Sort By:
Bioorganic & Medicinal Chemistry
|
March 23, 2005
Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation
Gary H Posner, S H Tony Lee, Hyung Jin Kim, et al.
Biochemical Pharmacology
|
November 22, 2008
Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent
Carmony L Hartwig, Andrew S Rosenthal, John D'Angelo, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 30, 2010
Vitamin D analogues targeting CYP24 in chronic kidney disease
Gary H Posner, Christian Helvig, Dominic Cuerrier, et al.
Plos One
|
September 10, 2011
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities
Ran He, Bryan T Mott, Andrew S Rosenthal, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
Modulation of response to estrogens in cultured human female bone cells by a non-calcemic Vitamin D analog: changes in nuclear and membranal binding
Dalia Somjen, Sara Katzburg, Orly Sharon, et al.
Journal of Medicinal Chemistry
|
February 2, 1999
Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family
G H Posner, M H Parker, J Northrop, et al.
Virology Journal
|
January 29, 2011
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
Ran He, Gordon Sandford, Gary S Hayward, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 13, 2006
Responsiveness to phytoestrogens in primary human osteoblasts is modulated differentially by a "less-calcemic" analog of 1,25 dihydroxyvitamin D(3): JK 1624F(2)-2 (JKF)
Dalia Somjen, Sara Katzburg, Fortune Kohen, et al.
Molecular Cancer Therapeutics
|
November 24, 2006
QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells
Sujatha Sundaram, Matthew J Beckman, Amandeep Bajwa, et al.
Journal of Medicinal Chemistry
|
March 7, 2003
Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy
Gary H Posner, Ik-Hyeon Paik, Surojit Sur, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 166) with videos related to
Sort By:
Page
of 17
Bioorganic & Medicinal Chemistry
|
March 23, 2005
Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation
Gary H Posner, S H Tony Lee, Hyung Jin Kim, et al.
Biochemical Pharmacology
|
November 22, 2008
Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent
Carmony L Hartwig, Andrew S Rosenthal, John D'Angelo, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 30, 2010
Vitamin D analogues targeting CYP24 in chronic kidney disease
Gary H Posner, Christian Helvig, Dominic Cuerrier, et al.
Plos One
|
September 10, 2011
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities
Ran He, Bryan T Mott, Andrew S Rosenthal, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
Modulation of response to estrogens in cultured human female bone cells by a non-calcemic Vitamin D analog: changes in nuclear and membranal binding
Dalia Somjen, Sara Katzburg, Orly Sharon, et al.
Journal of Medicinal Chemistry
|
February 2, 1999
Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family
G H Posner, M H Parker, J Northrop, et al.
Virology Journal
|
January 29, 2011
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
Ran He, Gordon Sandford, Gary S Hayward, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 13, 2006
Responsiveness to phytoestrogens in primary human osteoblasts is modulated differentially by a "less-calcemic" analog of 1,25 dihydroxyvitamin D(3): JK 1624F(2)-2 (JKF)
Dalia Somjen, Sara Katzburg, Fortune Kohen, et al.
Molecular Cancer Therapeutics
|
November 24, 2006
QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells
Sujatha Sundaram, Matthew J Beckman, Amandeep Bajwa, et al.
Journal of Medicinal Chemistry
|
March 7, 2003
Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy
Gary H Posner, Ik-Hyeon Paik, Surojit Sur, et al.
Page
of 17